GSK dividend analysis

GSK dividend deep dive

GSK dividend ledger: $4.48/share, 3.80% yield, 38% earnings payout, 0.8% 5-year CAGR. The streak of consecutive dividend increases stands at 9 years.

GSK dividend safety: 48/100. The score combines the company's Quality pillar (43/100) with the strain on free cash flow implied by the 38% payout. Risk pillar reads 35/100 alongside.

GSK DRIP scenario at $118.00 entry: 5-year horizon ≈ 20.7%, 10-year ≈ 45.6%, 20-year ≈ 112.1% on the income leg alone. Capital return depends on the multiple at exit and is not part of this number.

Peer dividend set for GSK (yield 3.80%): KO (5.00%), PG (1.50%), PEP (2.90%). The peer-mean yield prints 3.13%, so GSK sits above the cohort by 0.67 percentage points.

Distribution schedule for GSK: ex 2026-03-01, payment 2026-03-15. On a quarterly cadence at $1.120 per share, the annualized total works out to $4.48 — the figure used in the trailing yield calculation.

GSK closes the loop with a 3.80% / 0.8% / 48/100 yield-growth-safety triplet. The forward question for the next 12 months is whether earnings growth keeps pace with distribution growth at the current 38% payout.